Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$0.31 - $0.55 $1,500 - $2,662
4,841 Added 10.52%
50,854 $26,000
Q1 2023

May 01, 2023

BUY
$0.32 - $1.88 $14,724 - $86,504
46,013 New
46,013 $16,000
Q2 2022

Aug 09, 2022

BUY
$1.12 - $2.18 $13,221 - $25,734
11,805 New
11,805 $15,000
Q4 2021

Feb 17, 2022

SELL
$2.25 - $4.11 $79,501 - $145,222
-35,334 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$2.71 - $5.9 $95,755 - $208,470
35,334 New
35,334 $143,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.